ELOXX PHARMACEUTICALS INC (ELOX) Institutional Shareholders
ELOXX PHARMACEUTICALS INC (ELOX) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $34.70M in ELOX holdings during the latest filing period.
Aberdeen Group Plc is currently the largest disclosed institutional shareholder of ELOX tracked by InsiderSet, reporting ownership valued at approximately $5.55M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $6.98M, representing an estimated gain of +25.72% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 100% of the total disclosed ELOX value among the investors covered in this analysis. Major shareholders include Aberdeen Group Plc, Ecor1 Capital, Llc, Nantahala Capital Management, Llc, and several other long-term asset managers with concentrated positions in ELOXX PHARMACEUTICALS INC (ELOX).
This page ranks the largest institutional ELOX shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
22
Total Reported Value
$34.70M
Largest Holder
Aberdeen Group Plc
Largest Position
$5.55M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
22
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Aberdeen Group Plc | 0.01% | 400,000 | $5,552,000 | $6,980,000 | +$1,428,000 | +25.72% | |
| Ecor1 Capital, Llc | 0.28% | 400,000 | $5,552,000 | $6,980,000 | +$1,428,000 | +25.72% | |
| Nantahala Capital Management, Llc | 0.34% | 400,000 | $5,552,000 | $6,980,000 | +$1,428,000 | +25.72% | |
| Samsara Biocapital, Llc | 0.46% | 400,000 | $5,552,000 | $6,980,000 | +$1,428,000 | +25.72% | |
| Siren, L.L.C. | 0.11% | 400,000 | $5,552,000 | $6,980,000 | +$1,428,000 | +25.72% | |
| Stonepine Capital Management, Llc | 4.20% | 397,160 | $5,512,581 | $6,930,442 | +$1,417,861 | +25.72% | |
| Vanguard Capital Management Llc | 0.00% | 78,680 | $1,092,078 | $1,372,966 | +$280,888 | +25.72% | |
| Vanguard Fiduciary Trust Co | 0.00% | 10,602 | $147,156 | $185,005 | +$37,849 | +25.72% | |
| Seven Grand Managers, Llc | 0.01% | 10,000 | $138,800 | $174,500 | +$35,700 | +25.72% | |
| Morgan Stanley | 0.00% | 1,544 | $21,431 | $26,943 | +$5,512 | +25.72% | |
| Vanguard Global Advisers, Llc | 0.00% | 718 | $9,966 | $12,529 | +$2,563 | +25.72% | |
| Ubs Group Ag | 0.00% | 637 | $8,842 | $11,116 | +$2,274 | +25.71% | |
| Wells Fargo & Company/Mn | 0.00% | 126 | $1,749 | $2,199 | +$450 | +25.71% | |
| Pioneer Family Office, Llc | 0.00% | 96 | $1,332 | $1,675 | +$343 | +25.77% | |
| Royal Bank Of Canada | 0.00% | 98 | $1,000 | $1,710 | +$710 | +71.01% | |
| Altshuler Shaham Ltd | 0.00% | 25 | $347 | $436 | +$89 | +25.72% | |
| Barclays Plc | 0.00% | 12 | $167 | $209 | +$42 | +25.39% | |
| Towne Trust Company, N.A | 0.00% | 5 | $69 | $87 | +$18 | +26.45% | |
| Activest Wealth Management | 0.00% | 4 | $56 | $70 | +$14 | +24.64% | |
| Citigroup Inc | 0.00% | 4 | $56 | $70 | +$14 | +24.64% | |
| Sbi Securities Co., Ltd. | 0.00% | 2 | $28 | $35 | +$7 | +24.64% | |
| Point Nemo Capital, Llc | 0.00% | 1 | $14 | $17 | +$3 | +24.64% |
Frequently asked questions about ELOX
Who owns the most ELOX stock?
The largest holders of ELOX are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for ELOXX PHARMACEUTICALS INC (ELOX).
Is ELOX widely held by superinvestors?
Many widely followed stocks like ELOX appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly ELOX is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.